Read More Pharma Industry News VectivBio initiates phase 3 trial of apraglutide in patients with short bowel syndrome VectivBio, a leading Swiss biotechnology firm, has announced the commencement of patient dosing in its phase 3 STARS… bypharmanewsdailyFebruary 3, 2021